Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration 21 CFR Parts 520 and 524
[Docket No. FDA-2009-N-0665]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Final rule.
 SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for three new animal drug applications (NADAs) and one abbreviated new animal drug application (ANADA) from Virbac AH, Inc., to Cross Vetpharm Group Ltd.
 DATES: This rule is effective July 22, 2009.
 FOR FURTHER INFORMATION CONTACT: David R. Newkirk, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 240-276-8307, e-mail: 
                        *david.newkirk@fda.hhs.gov*.


SUPPLEMENTARY INFORMATION: Virbac AH, Inc., 3200 Meacham Blvd., Ft. 
                    ( print page 36112)
                    Worth, TX 76137, has informed FDA that it has transferred ownership of, and all rights and interest in, the following three approved NADAs and one approved ANADA to Cross Vetpharm Group Ltd., Broomhill Rd., Tallaght, Dublin 24, Ireland: Application No. (NADA/ANADA)
21 CFR Section
Product Name007-076
520.2325a
Sulfa-Nox (sulfaquinoxaline) Liquid008-244
520.2325a
Sulfa-Nox (sulfaquinoxaline) Concentrate049-729
520.2261a
PURINA Sulfa (sulfamethazine)200-318
524.1193
VIRBAMEC (ivermectin) Pour-On
 Accordingly, the agency is amending the regulations in 21 CFR 520.2261a, 520.2325a, and 524.1193 to reflect the transfer of ownership. This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808. List of Subjects in 21 CFR Parts 520 and 524 Animal drugs
 Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 520 and 524 are amended as follows: PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS
 1.The authority citation for 21 CFR part 520 continues to read as follows: Authority:
                        21 U.S.C. 360b. § 520.2261a
 2.In paragraph (a) of § 520.2261a, remove “051311 and 053501” and in its place add “053501 and 061623”. § 520.2325a
 3.In paragraph (a)(2) of § 520.2325a, remove “051311” and in its place add “061623”. PART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
 4.The authority citation for 21 CFR part 524 continues to read as follows: Authority:
                        21 U.S.C. 360b. § 524.1193
 5.In paragraph (b) of § 524.1193 remove “051311” and in numerical sequence add “061623”. Dated: July 14, 2009. Bernadette Dunham, Director, Center for Veterinary Medicine.


[FR Doc. E9-17356 Filed 7-21-09; 8:45 am] BILLING CODE 4160-01-S